The global healthcare landscape is witnessing a transformative shift in critical care management, with Extracorporeal Membrane Oxygenation (ECMO) emerging as a cornerstone for treating patients with severe cardiac and respiratory failure. As medical technology advances, the integration of more portable and efficient life-support systems is driving the market forward....

According to the latest report published by Data Bridge Market Research, the Smart Inhaler Technology Market Data Bridge Market Research analyses that the smart inhaler technology market which was USD 57.61 billion in 2021, would rocket up to USD 196.29 billion by 2029, and is expected to undergo a CAGR of 16.56% during the forecast period of 2022 to 2029. Smart Inhaler Technology...

As of January 22, 2026, the soft mist inhalers market is identifying as the fastest-growing segment of the respiratory drug delivery landscape, with its 2026 valuation reaching approximately $3.32 billion. The 2026 landscape is defined by a robust CAGR of 7.9% to 14.3%, as these devices gain significant traction over traditional pressurized metered-dose inhalers (pMDIs) and dry powder inhalers...